Why does a high-fat diet raise liver cancer risk decades later? A new MIT study traces the answer to a slow cellular identity shift that turns survival into vulnerability.

Tiny bubbles, big ambition: Researchers have developed ultra-simple, biocompatible microrobots that can autonomously navigate the body, home in on tumors, and release cancer drugs on demand. Powered by enzymes and guided by the tumor’s own chemical signals, the so-called “bubble bots” mark a major step toward smart, clinically viable drug delivery systems.

From tuberculosis to lung cancer, a new personalised lung-on-chip model opens the door to studying respiratory diseases in a realistic human system for the first time.

A new study has recommended to expand the universal age-based screening from the current 50-80 years to 40-85 years. The researchers estimate that this would help to detect 94 % of lung cancers and thus, prevent more than 26,000 extra deaths annually.

The Orion project is part of the flagship initiative, ‘Artificial Intelligence in the Life Sciences, from a Human Health Perspective’ by Swiss Federal Innovation Agency Innosuisse. The goal of the research project is to help improve the treatment of each cancer patient.

In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic.

A new study has identified that specialized immune cells within the glioblastoma tumor metabolize fructose to suppress immune responses and promote tumor growth. The study suggests that blocking this fructose metabolism may improve immunotherapy response.

The types of fats we consume directly impacts the survival and strength of the body’s immune cells and ability to fight disease, researchers have found.

The precise pH monitoring is crucial for the stability and performance of nanoparticles in drug delivery. Read how these biocompatible materials are developed and at what step the pH measurement is incorporated into the process.

Researchers have developed a mechanophenotyping cytometer — a microfluidic device designed to measure a cell’s physical size and squishiness. With the help of this new device, accurate measurements of changes in cell elasticity can be used to better understand diseases, diagnose patient symptoms and provide more accurate prognoses.